广发纳斯达克生物科技美元(001093)
动态评分： 5.90分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | MDGL | Madrigal Pharmaceuticals Inc | 101.59 | 0.58% |
| 2024-12-31 | HALO | 奥洛兹美医疗 | 91.8 | 0.53% |
| 2024-12-31 | CYTK | Cytokinetics Inc | 83.79 | 0.48% |
| 2024-12-31 | BPMC | Blueprint Medicines Corp | 83.64 | 0.48% |
| 2024-12-31 | IONS | Ionis Pharmaceuticals Inc | 83.31 | 0.48% |
| 2024-12-31 | NUVL | Nuvalent Inc-A | 77.54 | 0.45% |
| 2024-12-31 | TEM | Tempus AI Inc-A | 77.66 | 0.45% |
| 2024-12-31 | BBIO | BridgeBio Pharma Inc | 78.27 | 0.45% |
| 2024-12-31 | CRNX | Crinetics Pharmaceuticals Inc | 71.56 | 0.41% |
| 2024-12-31 | ALKS | 阿尔凯默斯 | 70.23 | 0.4% |
| 2024-12-31 | KRYS | Krystal Biotech Inc | 68.02 | 0.39% |
| 2024-12-31 | AXSM | Axsome Therapeutics Inc | 61.92 | 0.36% |
| 2024-12-31 | ACLX | Arcellx Inc | 62.57 | 0.36% |
| 2024-12-31 | ADMA | ADMA Biologics Inc | 61.2 | 0.35% |
| 2024-12-31 | SRRK | Scholar Rock Holding Corp | 61.08 | 0.35% |
| 2024-12-31 | APLS | Apellis Pharmaceuticals Inc | 59.91 | 0.34% |
| 2024-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 58.64 | 0.34% |
| 2024-12-31 | GH | Guardant Health Inc | 56.97 | 0.33% |
| 2024-12-31 | IMVT | Immunovant Inc | 54.88 | 0.32% |
| 2024-12-31 | ALVO | Alvotech | 53.29 | 0.31% |
公告&资料
